25th week of 2018 patent applcation highlights part 29 |
Patent application number | Title | Published |
20180170902 | COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | 2018-06-21 |
20180170903 | PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | 2018-06-21 |
20180170904 | PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | 2018-06-21 |
20180170905 | Method for Producing Sulfonyl Chloride Compound | 2018-06-21 |
20180170906 | THERAPEUTIC INHIBITORY COMPOUNDS | 2018-06-21 |
20180170907 | SALTS OF A PIM KINASE INHIBITOR | 2018-06-21 |
20180170908 | GLP-1 Agonists and Uses Thereof | 2018-06-21 |
20180170909 | PYRAZOLE DERIVATIVES AS MALT1 INHIBITORS | 2018-06-21 |
20180170910 | ALPHA-HELIX MIMETICS AS MODULATORS OF ABETA SELF-ASSEMBLY | 2018-06-21 |
20180170911 | PYRROLCARBOXAMIDE DERIVATIVES FOR THE INHIBITION OF ERK5 | 2018-06-21 |
20180170912 | SALICYLATE INHIBITORS OF MELK AND METHODS OF USE | 2018-06-21 |
20180170913 | MALEATE SALTS OF A QUINAZOLINE DERIVATIVE USEFUL AS AN ANTIANGIOGENIC AGENT | 2018-06-21 |
20180170914 | II(PI)-CONJUGATED COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, LIGHT-EMITTING MATERIAL, LIGHT-EMITTING THIN FILM, ORGANIC ELECTROLUMINESCENCE ELEMENT, DISPLAY DEVICE, AND ILLUMINATION DEVICE | 2018-06-21 |
20180170915 | 5-BROMO-INDIRUBINS | 2018-06-21 |
20180170916 | INHIBITORS OF CXCR2 | 2018-06-21 |
20180170917 | COMPOUNDS AND COMPOSITIONS AS RAF KINASE INHIBITORS | 2018-06-21 |
20180170918 | METHODS OF SYNTHESIZING A DIFLUOROLACTAM ANALOG | 2018-06-21 |
20180170919 | CRYSTALINE FORMS OF N-[6-(CIS-2,6-DIMETHYLMORPHOLINE -4-YL)PYRIDINE-3-YL]-2-METHYL-4'-(TRIFLUOROMETHOXY) [1,1'-BIPHENYL]-3-METHANAMIDE MONOPHOSPHATE, AND PROCESS OF PREPARATION THEREOF | 2018-06-21 |
20180170920 | 3-(6-CHLORO-3-OXO-3,4-DIHYDRO-(2H)-1,4-BENZOXAZIN-4-YL) PROPANOIC ACID DERIVATIVES AND THEIR USE AS KMO INHIBITORS | 2018-06-21 |
20180170921 | 3-(6-ALKOXY-5-CHLOROBENZO[D]ISOXAZOL-3-YL)PROPANOIC ACID USEFUL AS KYNURENINE MONOOXYGENASE INHIBITORS | 2018-06-21 |
20180170922 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | 2018-06-21 |
20180170923 | COMPOUNDS FOR THE TREATMENT OF CANCER | 2018-06-21 |
20180170924 | PI-KINASE INHIBITORS WITH ANTI-INFECTIVE ACTIVITY | 2018-06-21 |
20180170925 | NOVEL THERAPEUTIC AGENTS FOR THE TREATMENT OF HBV INFECTION | 2018-06-21 |
20180170926 | CRYSTAL OF 5-HYDROXY-4-(TRIFLUOROMETHYL)PYRAZOLOPYRIDINE DERIVATIVE | 2018-06-21 |
20180170927 | INHIBITORS OF RIP1 KINASE AND METHODS OF USE THEREOF | 2018-06-21 |
20180170928 | Methyl- and Trifluoromethyl-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use Thereof | 2018-06-21 |
20180170929 | PYRIMIDINE-2,4-DIAMINE DERIVATIVES FOR TREATMENT OF CANCER | 2018-06-21 |
20180170930 | 1,6- DIAZABICYCLO [3,2,1] OCTAN-7-ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS | 2018-06-21 |
20180170931 | Small Molecule Inhibitors of the JAK Family of Kinases | 2018-06-21 |
20180170932 | PURINE DIONES AS WNT PATHWAY MODULATORS | 2018-06-21 |
20180170933 | PURINONE DERIVATIVE | 2018-06-21 |
20180170934 | FOLATE DERIVATIVES, USEFUL IN PARTICULAR IN THE CONTEXT OF THE FOLATE ASSAY | 2018-06-21 |
20180170935 | 3,3-DIFLUOROPIPERIDINE CARBAMATE HETEROCYCLIC COMPOUNDS AS NR2B NMDA RECEPTOR ANTAGONISTS | 2018-06-21 |
20180170936 | PROCESS FOR THE PREPARATION OF BENZIMIDAZO[1,2-A] BENZIMIDAZOLES | 2018-06-21 |
20180170937 | NEW SOLID FORMS OF SITAGLIPTIN | 2018-06-21 |
20180170938 | BICYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS | 2018-06-21 |
20180170939 | BICYCLIC DIHYDROPYRIMIDINE-CARBOXAMIDE DERIVATIVES AS RHO- KINASE INHIBITORS | 2018-06-21 |
20180170940 | CRYSTALLINE FORMS OF A BRUTON'S TYROSINE KINASE INHIBITOR | 2018-06-21 |
20180170941 | BENZODIAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT | 2018-06-21 |
20180170942 | POLYCYCLIC DERIVATIVES TARGETING RAL GTPASES AND THEIR THERAPEUTICAL APPLICATIONS | 2018-06-21 |
20180170943 | PIPERIDINE DERIVATIVE AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF | 2018-06-21 |
20180170944 | USE OF THE FL-ONE HUNDRED EIGHTEEN CORE CHEMICAL STRUCTURE PLATFORM TO GENERATE FL-ONE HUNDRED EIGHTEEN DERIVATIVES FOR TREATMENT OF HUMAN DISEASE | 2018-06-21 |
20180170945 | CRYSTALLINE FORMS OF DARUNAVIR | 2018-06-21 |
20180170946 | INHIBITORS OF PTP4A3 FOR THE TREATMENT OF CANCER | 2018-06-21 |
20180170947 | HYDROXYESTER DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2018-06-21 |
20180170948 | COMPOUNDS TARGETING PROTEINS, COMPOSITIONS, METHODS, AND USES THEREOF | 2018-06-21 |
20180170949 | SYNTHESIS OF CEPHALOSPORIN COMPOUNDS | 2018-06-21 |
20180170950 | PROCESS FOR SEPARATING ALUMINUM CHLORIDE FROM SILANES | 2018-06-21 |
20180170951 | AMIDE-LINKED EP4 AGONIST-BISPHOSPHONATE COMPOUNDS AND USES THEREOF | 2018-06-21 |
20180170952 | PREPARATION OF RHODIUM(III)-2-ETHYLHEXANOATE | 2018-06-21 |
20180170953 | PROTOTYPE SYSTEMS OF THERANOSTIC BIOMARKERS FOR IN VIVO MOLECULAR MANAGEMENT OF CANCER | 2018-06-21 |
20180170954 | Process | 2018-06-21 |
20180170955 | HEXOSE DERIVATIVES, PREPARATION AND USES THEREOF | 2018-06-21 |
20180170956 | NOVEL PROCESS FOR PREPARING POLYOL GLYCOSIDES | 2018-06-21 |
20180170957 | HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS | 2018-06-21 |
20180170958 | CRYSTALLINE FORM A OF OBETICHOLIC ACID AND PREPARATION METHOD THEREOF | 2018-06-21 |
20180170959 | METHOD FOR PRODUCING ALPHA-FORM CRYSTAL OF REDUCED GLUTATHIONE, AND METHOD FOR STORING SAID CRYSTAL | 2018-06-21 |
20180170960 | Active-Form Mutant Enzyme Production Method, New Active-Form Mutant Enzyme, and Solubilized Mutant Protein Production Method | 2018-06-21 |
20180170961 | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE COMPRISING THE PEPTIDE HAVING THE ABILITY TO INHIBIT ANGIOTENSIN-1 CONVERTING ENZYME AS AN ACTIVE INGREDIENT | 2018-06-21 |
20180170962 | COMPOUNDS FOR PROTEASOME ENZYME INHIBITION | 2018-06-21 |
20180170963 | CONOTOXIN PEPTIDE K-CPTX-BTL04, PREPARATION METHOD THEREFOR, AND USES THEREOF | 2018-06-21 |
20180170964 | Novel Peptides and Analogs for Use in the Treatment of Oral Mucositis | 2018-06-21 |
20180170965 | PEPTIDE HAVING ANTIMICROBIAL ACTIVITY AGAINST PATHOGENS AND ANTIMICROBIAL PEPTIDE COMPOSITION COMPRISING THE SAME | 2018-06-21 |
20180170966 | PEPTIDE FOR SUPPRESSING OSTEOCLAST DIFFERENTIATION AND USE THEREOF | 2018-06-21 |
20180170967 | STAPLED PEPTIDES AND USES THEREOF | 2018-06-21 |
20180170968 | Poultry Farm Practices | 2018-06-21 |
20180170969 | COMPOSITIONS AND METHODS FOR TREATING DISEASES BY INHIBITING EXOSOME RELEASE | 2018-06-21 |
20180170970 | VIRAL CHIMERIC PARTICLE OF POTATO VIRUS X AND USE THEREOF FOR IN VITRO DIAGNOSIS OF SJOGREN SYNDROME | 2018-06-21 |
20180170971 | IMMUNOGENS FOR HIV VACCINATION | 2018-06-21 |
20180170972 | Adenovirus Polynucleotides and Polypeptides | 2018-06-21 |
20180170973 | IMMUNOGLOBULIN-BINDING MODIFIED PROTEIN | 2018-06-21 |
20180170974 | VACCINE AGAINST S. SUIS INFECTION | 2018-06-21 |
20180170975 | IMMUNOGENIC COMPOSITIONS COMPRISING MYCOBACTERIUM TUBERCULOSIS POLYPEPTIDES AND FUSIONS THEREOF | 2018-06-21 |
20180170976 | PLANT TRANSCRIPTIONAL REGULATORS | 2018-06-21 |
20180170977 | CYCLIC RGD CELL-BINDING MOTIF AND USES THEREOF | 2018-06-21 |
20180170978 | MODULAR ANTIGEN TRANSPORTATION MOLECULES AND USES THEROF | 2018-06-21 |
20180170979 | FUSION PROTEINS FOR INHIBITING ANGIOGENESIS | 2018-06-21 |
20180170980 | NOVEL POLYPEPTIDE CAPABLE OF BINDING TO VASCULAR ENDOTHELIAL GROWTH FACTOR, AND USE THEREOF | 2018-06-21 |
20180170981 | RECOMBINANT POLYPEPTIDE FOR ENHANCING CELL TRANSDUCTION EFFICIENCY OF A TARGET AGENT | 2018-06-21 |
20180170982 | METHODS OF MODIFYING TRANSCRIPTIONAL REGULATORY NETWORKS IN STEM CELLS | 2018-06-21 |
20180170983 | New Use of Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway for the Treatment of Mild Cognitive Impairment | 2018-06-21 |
20180170984 | SITE-SPECIFIC DNA BASE EDITING USING MODIFIED APOBEC ENZYMES | 2018-06-21 |
20180170985 | CRISPR-BASED METHODS AND PRODUCTS FOR INCREASING FRATAXIN LEVELS AND USES THEREOF | 2018-06-21 |
20180170986 | CANCER ANTIGEN HELPER PEPTIDE | 2018-06-21 |
20180170987 | CRYPTIC POLYPEPTIDES AND USES THEREOF | 2018-06-21 |
20180170988 | BMP-7 PEPTIDES AND METHODS OF USE | 2018-06-21 |
20180170989 | Targeted Modified TNF Family Members | 2018-06-21 |
20180170990 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF NUCLEAR PROTEINS | 2018-06-21 |
20180170991 | LONG-ACTING ADRENOMEDULLIN DERIVATIVES | 2018-06-21 |
20180170992 | CAR T CELLS RECOGNIZING CANCER-SPECIFIC IL 13Ra2 | 2018-06-21 |
20180170993 | Bi-targeted Mutain MuR6S4TR of TRAIL and Preparation Method and Application Thereof | 2018-06-21 |
20180170994 | Bi-targeted Mutain MuR5S4TR of TRAIL and Preparation Method and Application Thereof | 2018-06-21 |
20180170995 | P75NTR -FC FUSION PROTEIN | 2018-06-21 |
20180170996 | METHOD OF DIAGNOSIS OR TREATMENT OF NEUROLOGICAL DISORDERS WITH P75ECD AND/OR P75 | 2018-06-21 |
20180170997 | NOVEL EPITOPE FOR SWITCHING TO TH17 CELL AND USE THEREOF | 2018-06-21 |
20180170998 | AML ANTIGENS AND USES THEREOF | 2018-06-21 |
20180170999 | BTLA FUSION PROTEIN AGONISTS AND USES THEREOF | 2018-06-21 |
20180171000 | RECOMBINANT LIPOPROTEIN MODIFIED BY MONOSIALOTETRAHEXOSYL GANGLIOSIDE AND APPLICATION THEREOF | 2018-06-21 |
20180171001 | Broadly Neutralizing Anti-HIV Antibodies and Epitope Therefor | 2018-06-21 |